We are looking forward to meeting you in person at the follwing events.
36th Annual Meeting & Pre-Conference Programs (SITC)
Our partner Edesa Biotech announced positive Phase 2 Data for the licensed anti-TLR4 monoclonal antibody in hospitalized COVID-19 patients
A Swiss biotech success story award has been attributed to Novimmune at the recent Swiss Biotech days held in Basel.
"PARLONS ECONOMIE" - Is the future of medicine taking shape in Geneva?
